Orexigen Therapeutics (OREX) News Today → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free OREX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineXeno Biosciences Announces New CEO and Financingbusinesswire.com - April 17 at 1:55 PMOrexigen Tanks After-Hours on Obesity Datathestreet.com - August 27 at 3:45 AMRegulus Therapeutics Inc.: Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updatesfinanznachrichten.de - August 9 at 2:08 PMTriumvira Immunologics Strengthens its Leadership Team with Three Accomplished Life Sciences Executivesfinance.yahoo.com - July 20 at 8:36 AMMAPLIGHT THERAPEUTICS APPOINTS KRIS HANSON AS GENERAL COUNSELmarkets.businessinsider.com - June 20 at 6:09 PM2023 "Anti-obesity Drugs Market" Key Manufacturers and Regional Outlook 2031marketwatch.com - May 17 at 8:21 AMGlobal Anti-obesity Medicine Market Size 2023-2031 Market Dynamics by Absolute Reports | with [86 Pages]marketwatch.com - May 16 at 10:49 AMThe global Weight Loss Therapeutics market Size during the period of 2023 to 2030 is expected grow at CAGR of 11.3%marketwatch.com - May 5 at 9:14 PMZevra Therapeutics Appoints Biopharma Veteran Wendy Dixon, Ph.D., to Board of Directorsfinance.yahoo.com - March 30 at 12:33 PMAnti-Obesity Drugs Market Factual Overview Research Report 2023-2030marketwatch.com - March 30 at 7:33 AMGlobal Anti-Obesity Drugs Market Size 2023 to 2026 Size and Share Survey Reportmarketwatch.com - March 29 at 10:55 AMAnti Obesity Drugs Market Size and Forecast till 2028marketwatch.com - March 28 at 6:16 PMAnti-Obesity Drugs Market New Innovations and Future Expansion 2023-2031marketwatch.com - March 28 at 1:15 PMAnti-Obesity Drugs (Anti-obesity Medication) Market Share and Forecast till 2028marketwatch.com - March 21 at 8:37 AMAnti Obesity Drugs Market Continues Aggressive Growth till 2028marketwatch.com - March 13 at 8:40 PMThe Weight Loss Therapeutics Market 2023 is Expected to Udergo Significant Changes Due to New Technologies and Other Industry Related Factors 2030marketwatch.com - March 8 at 11:44 AM2023-2029 Anti-Obesity Prescription Drugs Market Size and Growth Analysis | Research Report by Absolute Reportsmarketwatch.com - March 6 at 2:56 AMAnti-obesity Drugs Market International Business Analysis, Development Outlook and Regional Strategies 2028marketwatch.com - February 23 at 2:39 AMWeight Loss Therapeutics Market Shows Huge Demand by Shares, Size, Future Trends and Future Scope Including Top Players by 2023-2028marketwatch.com - December 8 at 8:27 AMAnti-obesity Medicine Market 2023 | Future Growth Segments, Latest Opportunities, Industry Revenue, Size, Share and Leading Players Forecast to 2028marketwatch.com - November 18 at 12:25 PMWeight Loss Therapeutics Market Size And Opportunities for New Players, Forecast from 2022 To 2028marketwatch.com - October 13 at 5:58 PMOrexigen to Post Obesity Data in Race With Vivus, Arenathestreet.com - September 6 at 8:20 PMObesity Management Market Size 2022 : Technological Advancements in Report & Recent Innovations, Value Chain Analysis Till 2028 | 87 Report Pagesmarketwatch.com - September 6 at 3:20 PMOrexigen Weight-Loss Pill Shows Surprise Heart-Safety Benefitthestreet.com - August 22 at 12:49 AMAnti-obesity Drugs Market Size 2022 Share, Growth By Top Company, Business Opportunity, Region, Application, Driver, Trends and Forecasts By 2028marketwatch.com - August 17 at 9:54 PMAnti-obesity Medicine Market Size to rise at 16.2% CAGR through 2028marketwatch.com - July 23 at 7:00 AMLilly's experimental obesity drug may be a 'multibillion-dollar opportunity'morningstar.com - May 2 at 1:41 PMLilly's experimental weight-loss drug may be a 'multibillion-dollar opportunity'morningstar.com - April 30 at 10:57 PMBinge Eating Disorder Market Global Trends, Segmentation and Opportunities Forecast To 2027marketwatch.com - April 25 at 7:56 AMHow Will Orexigen Therapeutics (OREX) Stock Respond to FDA's Contrave Approval?thestreet.com - January 15 at 12:43 AMMetropolitan West Total Return Bond Fund Plan Class (MWTSX)finance.yahoo.com - November 17 at 8:05 AMNavamedic ASA extends exclusive distribution rights for Mysimba in the Nordicsfinance.yahoo.com - October 12 at 8:26 AMFederal Courts Make 2 Basic Errors In Virus Coverage Rulingslaw360.com - September 30 at 9:13 PMSesen Bio Strengthens Executive Leadership Team as the Company Approaches the Potential Approval and Commercial Launch of Vicineum™in.finance.yahoo.com - August 11 at 8:17 AM Get Orexigen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OREX and its competitors with MarketBeat's FREE daily newsletter. Email Address Automatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. OREX Media Mentions By Week OREX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OREX News Sentiment▼0.000.42▲Average Medical News Sentiment OREX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OREX Articles This Week▼00▲OREX Articles Average Week Get Orexigen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OREX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CNTX News LVTX News MYNZ News NLSP News PHVS News PROC News QLI News TLSA News ACONW News DRTSW News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OREX) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orexigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
